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correlations, and multiple linear regression analyses were 
completed to describe participants, the associations of the 
variables of interest, and the unique relationship between 
psychosocial variables and HRQOL.
Results Overall, participants reported poor HRQOL 
(M = 63.32, range 0–100). Catastrophizers differed signifi-
cantly on IBS-QOL from non-catastrophizers (M = 48.98 
vs. non-catastrophizers M = 78.53; p < 0.001), BSI-18 
(M = 21.35 vs. non-catastrophizers M = 6.76; p < 0.001), 
and IPQ-R, specifically the consequences (M = 21.75 
vs. non-catastrophizers M = 17.20; p < 0.001) and emo-
tional representations (M = 20.90 vs. non-catastrophizers 
M = 15.43; p < 0.001). Catastrophizing was positively cor-
related with the consequences (r = .54; p < 0.01) and emo-
tional representations (r = .65; p < 0.01) and negatively cor-
related with total HRQOL (r = −0.76; p < 0.01).
Conclusion The findings indicated that participants who 
catastrophized reported worse psychosocial and functional 
outcomes. Thus, catastrophizing, in addition to psycho‑
logical distress variables, may be an important factor to 
address in optimizing health outcomes in individuals with 
IBS. In addition, illness perceptions were strongly related 
to catastrophizing and HRQOL; assessment and integration 
of illness perceptions as well as catastrophizing into the 
management of individuals who suffer with IBS may maxi-
mize the health outcomes.
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Introduction
Irritable bowel syndrome (IBS) is a highly prevalent 
chronic gastrointestinal disorder designated by abdominal 
Abstract 
Background Catastrophizing is a cognitive process char-
acterized by a propensity to concentrate on and magnify 
the value of an actual or anticipated painful stimulus and 
negatively assesses one’s ability to cope. Catastrophiz-
ing is an important predictor of pain-related outcomes. A 
cornerstone symptom of irritable bowel syndrome (IBS) is 
abdominal pain or discomfort. Also individuals with IBS 
have been reported to have a tendency to catastrophize. In 
a sample of individuals who suffer from IBS, we hypoth-
esized that those individuals who catastrophize (catastro-
phizers) would have worse outcomes as compared to those 
who do not catastrophize (non-catastrophizers).
Methods One hundred and one adults with IBS (79% 
female, mean age 42 years, 97% Caucasian) were recruited 
from outpatient clinics and data were collected through 
self-report measures. Catastrophizing was measured with 
the catastrophizing subscale of the Coping Strategies Ques-
tionnaire, illness representations were measured with The 
Revised Illness Perception Questionnaire (IPQ-R), psy-
chological distress was measured with the Brief Symp-
tom Inventory 18 (BSI-18), and health-related quality of 
life was measured using the Irritable Bowel Syndrome-
Quality of Life (IBS-QOL) measure. Descriptive statistics, 
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pain or discomfort and associated bowel habit changes [1]. 
The symptoms, hardships, and impairments characterize 
IBS rather than organic abnormalities. Dilemmas concern-
ing diagnosis and the variability of symptoms combined 
with the complex interaction of factors that impact biologi-
cal, psychological, and social aspects for an individual with 
IBS contribute to treatment challenges [2]. The biopsycho-
social model presents the relationships between psychoso-
cial factors (life stress, psychological state, social support, 
and coping), physiological factors (motility, sensation, 
inflammation, and microbiome), symptoms and behaviors, 
and clinical outcomes (quality of life, doctor visits, func-
tioning, and medical treatments).
Impairment of quality of life and maladaptive coping 
have been found in those who suffer from irritable bowel 
syndrome [3, 4]. Additionally, Rutter and Rutter [3] found 
that adaptive coping can enhance outcomes such as quality 
of life and satisfaction with health. Likewise, coping was 
found to mediate the relationship between illness represen-
tations and outcomes. Maladaptive coping, such as cata-
strophizing, has been found to be endorsed by individuals 
with IBS [5]. The construct catastrophizing is broadly per-
ceived as an exaggerated negative “mental set” that comes 
to be when an individual is experiencing pain or is antici-
pating a pain experience [6]. It is a “method of cognitively 
coping that is characterized by negative self-statements and 
overly negative thoughts and ideas about the future” [7]. 
Catastrophizing has been associated with increased pain 
severity, disability and functional limitations, decreased 
quality of life, and worsening disease activity as measured 
by physiologic indices in those with rheumatoid diseases 
[8]. Specific to IBS, van Tilburg et al. [5] observed a direct 
association between catastrophizing and IBS severity; in 
addition, catastrophizing was found to mediate the relation-
ship between anxiety and IBS severity. Individuals with 
IBS often experience comorbid psychiatric disorders such 
as anxiety, depression, and somatization [9, 10]. These 
psychological comorbidities have been reported to have a 
negative impact on IBS symptom severity [5] and health-
related quality of life [11] and are strong predictors of psy-
chological functioning [12, 13]. Accordingly, the intrinsic 
perceptions or illness representations of individuals are 
important roots to their IBS.
The common sense model (CSM) of illness representa-
tions was developed by Leventhal and colleagues [14] and 
expanded to include parallel emotional representations 
[15]. Illness representations are classified into the follow-
ing categories: identity (the label and symptoms associ-
ated with an illness), timeline (beliefs regarding the time 
of development and duration), consequences (the ramifica-
tion of the illness on the psychological, social, and physical 
functioning), cause (the individual’s belief about potential 
cause(s) of their illness), control (the belief regarding the 
amount of control the individual has regarding their ability 
to control symptoms and the belief in the provider to inter-
cede and influence symptoms), and emotional representa-
tion (the negative impact of their illness on their emotional 
well-being). According to the CSM, illness representations 
and coping influence outcomes.
Research examining the role of catastrophizing and ill-
ness representations in IBS is limited. Therefore, the aim 
of the present study was to investigate the relevance of 
catastrophizing to patient-reported illness representations, 
psychological distress, and health-related quality of life. 
Specifically, the main focus of the study was to investigate 




Self-reported questionnaires were used in this cross-sec-
tional descriptive study. Participants were recruited by phy-
sician referral and by advertisement in community-based 
gastrointestinal practices located in Idaho and Connecticut. 
The study was approved by the institutional review board 
of Oregon Health & Science University with a waiver of 
consent. The study population consisted of patients with an 
active diagnosis of IBS consistent with Rome III criteria. 
Participants were excluded if they had a new onset (within 
the past 6  months) of an organic gastrointestinal disorder 
involving the lower gastrointestinal tract (i.e., inflamma-
tory bowel disease, microscopic colitis, collagenous colitis, 
colonic strictures or malignancy).
Measures
Participant characteristics
A demographic questionnaire was used to collect informa-
tion such as age, gender, race/ethnicity, highest education 
level achieved, current employment status, length of time 
since diagnosis, and medications taken for the treatment of 
depression and/or anxiety.
Illness representations
The Revised Illness Perception Questionnaire (IPQ-R) was 
used to quantify the components of illness representation. 
The subscales included were identity, consequences, time-
line-acute/chronic, timeline cyclical, treatment and personal 
control, illness coherence, emotional representation, and 
cause. The items were rated on a 5-point scale except for 
the identity scale. The identity scale included 14 commonly 
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experienced symptoms. The participant was asked to indi-
cate whether they experienced any of the symptoms since 
their IBS diagnosis and whether they believe that the symp-
toms listed were related to their IBS. The cause scale lists 
18 potential causes associated with IBS. Good reliability 
and validity were demonstrated in all subscales [15].
Health‑related quality of life
The Irritable Bowel Syndrome-Quality of Life (IBS-QOL) 
questionnaire was used to quantify the level of health-
related quality of life, including global and subscale meas-
urement. The 34 items were rated on a 5-point scale that 
ranged from “not at all” to “extremely or a great deal,” 
where higher scores imply better quality of life. Internal 
consistency and reliability were demonstrated [16].
Catastrophizing
The catastrophizing subscale of the Coping Strate-
gies Questionnaire was used and includes six items that 
reflected the participant’s feelings of hopelessness and 
worsening pain expectation. Participants were classified as 
catastrophizers and non-catastrophizers, using median split 
to ensure that categorization was balanced and accurately 
reflected the true “split” for this sample [17, 18]. Good 
reliability and validity have been shown in chronic pain 
patients in addition to IBS patients using the Coping Strate-
gies Questionnaire subscale [19].
Psychological distress
The Brief Symptom Inventory 18 (BSI-18) was used to 
quantify the levels of anxiety, depression, and somatiza-
tion over the previous 7 days. Items were rated on a 5-point 
scale that ranged from “not at all” to “extremely” where 
greater scores imply higher levels of anxiety, depression, 
and somatization. The BSI-18 has good internal consist-
ency and validity [20, 21].
Average pain numeric rating scale
Abdominal pain intensity over the previous 7  days was 
rated on an 11-point numeric rating scale. Item anchors 
ranged from “no pain” to “worst pain possible,” where 
higher scores imply higher pain levels [22].
Data analysis
Descriptive statistics of the participants were calculated 
and frequency tables (categorical variables) or measures 
of central tendency and spread (continuous variables) 
were reported. Due to the ordinal nature of the measures, 
Spearman correlations were used to measure the associa-
tion between measures of interest. Because of the non-
normal nature of the data, Wilcoxon Rank-Sum Tests 
were used to compare the scores for participants who 
were categorized as catastrophizers and non-catastro-
phizers. Chi-square analyses and Fisher’s Exact test were 
used to evaluate the associations between categorical var-
iables. All assumptions were checked; if the Chi-square 
assumption was not met, data were dichotomized in 
order to use Fisher’s Exact test for categorical data. Only 
independent variables significantly associated with the 
HRQOL at the bivariate level of analysis were included 
as predictor variables in the subsequent multivariate anal-
ysis. Multiple linear regression analysis was conducted to 
predict the HRQOL using catastrophizing and psychoso-
cial variables after controlling for age, gender, and pain. 
All analyses were conducted with SAS® software, ver-
sion 9.4 (Copyright © 2012 SAS Institute Inc.) or Statis-
tical Package for Social Sciences for Windows, version 
23.0 (IBM SPSS version 23.0, Chicago, Illinois).
Results
Participant characteristics
A total of 101 IBS patients participated. The mean age 
was 42.08 years (SD = 5.84; age range 30–50 years). Par-
ticipants were predominantly female (78.22%), Caucasian 
(96.04%), and had at least 4 years of college (Bachelor’s 
degree or higher 49.50%) or some college/vocational or 
technical education (23.76%). For the entire study cohort, 
there was no significant difference in age, gender, mari-
tal status (69% married), race, or employment (58% 
full-time) between catastrophizers (N = 52) and non-
catastrophizers (N = 49). Participant-reported pain levels 
in the past week (catastrophizers median 5.0 vs. non-
catastrophizers median 3.0) were statistically different 
(p ≤ 0.0001; Wilcoxon Rank-Sum Test). Fifty-five percent 
of the overall participants took medication for the treat-
ment of depression, anxiety, or both and 60.39% had been 
diagnosed with IBS for 5 or more years.
Catastrophizing
Group categorization of catastrophizers and non-cata-
strophizers used the median split catastrophizing score 
of 7.00 (range = 0–36). The median split resulted in a 
group of catastrophizers (n = 52) and non-catastrophizers 
(n = 49).




Emotional representation and consequences were sig-
nificantly higher in catastrophizers as compared to 
non-catastrophizers (Figs.  1, 2). The remaining illness 
representations (timeline-acute/chronic/cyclical, cure/
control-personal/treatment, identity, illness coherence) 
did not differ significantly between catastrophizers and 
non-catastrophizers.
Fig. 1  Emotional representa-
tion by catastrophizing cat-
egory with mean, median, and 
standard deviation of emotional 
representation for each group 
(p = 0.001)
Fig. 2  Consequence score by 
catastrophizing category with 
mean, median, and standard 
deviation of consequence for 
each group (p = 0.0002)
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Causal representation
The overall cohort most commonly reported causal attri-
butions were “risk factors” (hereditary, diet, poor medi-
cal care, own behavior, aging, smoking, or alcohol) (53%) 
and psychological attributions (46%). Only one participant 
identified immunity (germ/virus, pollution in the environ-
ment or altered immunity) as a cause of their IBS. Catastro-
phizers did not differ significantly from non-catastrophizers 
on their causal reporting.
IBS quality of life
Overall, participants reported poor HRQOL (M = 63.32, 
median = 63.97, range 0–100). However, the quality-of-
life scores were significantly lower in catastrophizers 
(M = 48.98; median = 48.90; p ≤ 0.001) as compared to non-
catastrophizers (M = 78.53, median = 80.88). Furthermore, 
all subscales significantly differed between the groups 
(Table 1). Catastrophizers were noted to endorse lower lev-
els of subscale values, implying that IBS had a significant 
negative impact on their physical and psychological well-
being as compared to non-catastrophizers.
Psychological distress
The BSI-18 global severity index scores were significantly 
higher in catastrophizers (M = 21.35, median = 21.00; 
SD = 13.82; range = 0–68; p ≤ 0.001) than in non-catastro-
phizers (M = 6.76, median = 4.00; SD = 8.00; range = 0–13; 
p ≤ 0.001). When the distribution of the three psychological 
distress categories (anxiety, depression, and somatization) 
was compared between catastrophizers and non-catastro-
phizers, the difference was highly significant (p ≤ 0.001; 
Table 1).
Table 1  Description of the 
measures by catastrophizing 
category (mean, median, 
standard deviation, and 
significance)
HRQOL health-related quality of life as measured by the IBS-QOL (Irritable Bowel Syndrome-Quality of 
Life) condition-specific measure, BSI—18 Brief Symptom Inventory-18
Catastrophizing category Variable Mean Median SD p value
Catastrophizers Total HRQOL 48.98 48.89 20.18 ≤0.0001
Non-catastrophizers Total HRQOL 78.53 80.88 14.08
HRQOL subscales
 Catastrophizers Body image 48.20 50.00 23.00 ≤0.0001
 Non-catastrophizers Body image 71.30 75.00 21.91
 Catastrophizers Dysphoria 49.34 53.13 25.47 ≤ 0.0001
 Non-catastrophizers Dysphoria 84.89 90.63 13.92
 Catastrophizers Food avoidance 35.26 33.33 30.53 ≤0.0001
 Non-catastrophizers Food avoidance 62.93 66.67 28.33
 Catastrophizers Health-worry 50.16 54.17 22.66 ≤0.0001
 Non-catastrophizers Health-worry 77.38 83.33 19.10
 Catastrophizers Interference with activity 42.72 42.86 23.04 ≤0.0001
 Non-catastrophizers Interference with activity 75.51 75.00 18.59
 Catastrophizers Relationships 62.98 66.67 24.33 ≤0.0001
 Non-catastrophizers Relationships 86.90 91.67 14.63
 Catastrophizers Sexual 54.57 62.50 34.48 ≤0.0001
 Non-catastrophizers Sexual 79.85 100.00 26.12
 Catastrophizers Social reaction 56.13 59.38 29.72 ≤0.0001
 Non-catastrophizers Social reaction 83.93 87.50 15.78
BSI-18
 Catastrophizers Global severity index 21.35 21.00 13.82 ≤0.001
 Non-catastrophizers Global severity index 6.76 4.00 8.00
BSI-18 subscales
 Catastrophizers Somatization 8.19 6.00 6.07 ≤0.001
 Non-catastrophizers Somatization 3.51 2.00 4.19
 Catastrophizers Anxiety 7.35 7.50 5.58 ≤0.001
 Non-catastrophizers Anxiety 1.96 1.00 2.58
 Catastrophizers Depression 5.81 4.00 5.57 ≤0.001
 Non-catastrophizers Depression 1.29 0.00 2.17
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Correlations
Overall, catastrophizing was positively associated with 
the identity, consequences, and emotional representations 
and negatively associated with HRQOL total and sub-
scales (Table 2). In addition, total HRQOL was negatively 
associated with psychological distress variables: anxiety 
(r = −.66; p ≤ 0.001), depression (r = −.60; p ≤ 0.001), som-
atization (r = −.51; p ≤ 0.001), and global severity index 
(r = −.68; p ≤ 0.001), as well as pain experienced in the pre-
vious week (r = −.54; p ≤ 0.001).
Multiple regression
Multiple linear regression of the variables influencing 
HRQOL in IBS included six independent predictor varia-
bles (catastrophizing, anxiety, somatization, depression, the 
interaction between anxiety and somatization, and anxiety 
and depression) with total HRQOL scores from the IBS-
QOL as the dependent variable (Table  3). The resultant 
analysis revealed that catastrophizing, anxiety, somatiza-
tion, depression, and the interaction of anxiety and somati-
zation, and anxiety and depression each independently pre-
dicted poorer HRQOL independent of covariates (age, sex, 
and pain). The model had an R2 of 0.79, suggesting that 
over three quarters of the observed variability in HRQOL 
was accounted for by this model. Catastrophizing was the 
single greatest predictor of HRQOL accounting for 32% 
of total HRQOL variability. Psychological distress vari-
ables together accounted for a small amount of variability 
in participants’ HRQOL (15%), with anxiety accounting for 
the greatest amount of variance, 8%, and the interaction of 
anxiety and somatization, and anxiety and depression con-
tributing 3 and 4%, respectively.
Discussion
The main focus of this study was to examine whether the 
use of catastrophizing coping impacted the health-related 
quality of life, psychological distress, and illness percep-
tions of adults who suffer from IBS. Catastrophizing, an 
important psychological concept with limited previous 
research in IBS, was found to be significantly endorsed in 
this sample. Furthermore, individuals who catastrophized 
reported worse health-related quality of life, higher psy-
chological distress, and perceived more somatic symptoms, 
Table 2  Spearman correlations among health-related quality of life (total and subscales), catastrophizing coping style, and illness representation 
components (N = 101)
HRQOL health-related quality of life; CCS catastrophizing coping style; NS non-significant; 1 identity; 2 consequences; 3 timeline, acute/
chronic; 4 personal control; 5 treatment control; 6 illness coherence; 7 timeline cyclical; 8 emotional representation
*p ≤ 0.05, **p ≤ 0.001
HRQOL CCS 1 2 3 4 5 6 7 8
HRQOL total −0.47** −0.72** −0.34** 0.39** 0.39** 0.40** −0.18 −0.71**
Catastrophizing coping style −0.76** 0.39** 0.54** 0.27** −0.39** −0.35** −0.33** 0.20 0.65**
HRQOL subscales
Body image −0.54** −0.40** −0.42* NS −0.28* −0.28* 0.32** 0.19* −0.52**
Dysphoria − 0.73** −0.26** −0.66** 0.32** 0.44** −0.36** 0.41** NS −0.78**
Food avoidance − 0.51** − 0.26* − 0.52** − 0.20* NS NS 0.23* − 0.25* − 0.48**
Health-worry −0.64** −0.40** −0.47** NS 0.24* 0.38** 0.32** −0.21* −0.54**
Interference with activity −0.69** −0.37** −0.64** −0.22** 0.31** 0.30* 0.48** −0.25* −0.59**
Relationships −0.56** −0.28* −0.65** −0.29** 0.32** 0.33** 0.34** NS −0.61**
Sexual −0.46** −0.39** −0.60** −0.23* 0.31** 0.35** 0.25* NS −0.47**
Social reaction −0.55** −0.25* −0.57** −0.29* 0.22* 0.27* 0.23* NS −0.60**
Illness representation components
1. Identity 0.44** 0.15 −0.25* −0.24* −0.27** NS 0.35**
2. Consequences 0.43** −0.41** −0.58** −0.32** NS 0.65**
3. Timeline, acute/chronic −0.30** −0.44** −0.23** NS 0.28**
4. Personal control 0.61** 0.54** NS −0.44**
5. Treatment control 0.35** NS −0.43**
6. Illness coherence NS −0.38**
7. Timeline cyclical NS
8. Emotional representation
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worse consequences, and more severe emotional impact as 
compared to those participants who did not catastrophize.
Catastrophizing was positively associated with conse-
quences, emotional, identity, and timeline representations 
and negatively associated with health-related quality of 
life, control, and coherence representations. These findings 
indicate that individuals who catastrophized associated a 
greater number of symptoms with their IBS and catego-
rized their IBS as more chronic in nature and perceived 
worse consequences and a worse emotional impact. Alter-
natively, those reporting greater personal and treatment 
control and greater understanding of IBS were associated 
with a better health-related quality of life.
The role of catastrophizing in illness perceptions has 
not previously been reported in an IBS population. Previ-
ous research has confirmed the association between cata-
strophizing and depression, and pain severity [6, 23–25]. In 
addition, catastrophizing has been found to be a mediator 
between psychological distress and pain [26] and attach-
ment style and symptom severity [27]. Our findings further 
highlight the importance of this cognitive coping style fre-
quently associated with IBS.
Additionally, it is important to mention that we found 
psychological distress (anxiety, depression, and somati-
zation) was significantly associated with impairment of 
HRQOL. The main effects and interaction between anxi-
ety and depression explained a third of the variation that 
catastrophizing or pain explained. Of the psychological 
distress variables, anxiety was the greatest predictor of 
HRQOL impairment. The literature has established that 
individuals with IBS often experience comorbid psycho-
logical distress [5, 11, 28–30] and psychological distress 
is consistently found to negatively impact patient’s qual-
ity of life as measured by physical and mental functioning 
[12]. In addition, van Tilburg et al. (2013) have found that 
psychological distress (anxiety) relation to IBS symptom 
severity was mediated by catastrophizing [5]. It is impor-
tant to keep in mind the impact psychological factors have 
on individuals who suffer from IBS, especially with regard 
to their HRQOL. However, given the results of this study, 
it may be prudent to also consider the maladaptive coping 
skills, in particular catastrophizing coping, as the findings 
of our study suggest that maladaptive coping in addition to 
psychological distress may play an important role in IBS 
outcomes.
Medical treatment modalities in IBS have had limited 
success [31, 32]. The influence catastrophizing has on the 
well-being of individuals with IBS suggests directions for 
the design of psychosocial interventions targeted toward 
catastrophizing as a possible means to positively impact 
behavior and functioning. Influencing outcomes positively 
with Cognitive Behavior Therapy (CBT) has been reported 
in the pain literature [33, 34], as well as in IBS [35]. How-
ever, varying duration, intervention methods, effect sizes, 
and diversity of CBT formats contribute to treatment incon-
sistencies and varying benefits. Thorn and colleagues [33] 
have developed a CBT program that centers on the dimin-
ishment of catastrophizing. The authors report a clinical 
observation that those with chronic pain respond to adap-
tive coping training only after they become aware of their 
catastrophizing. Research to assess and direct treatment 
specifically focused at reducing catastrophizing resulting in 
positive outcomes is needed. Such research would provide 
healthcare providers with greater insight into the mecha-
nisms of change.
In addition to focusing treatment regimens on catastro-
phizing, addressing illness representations also appears 
to be a pertinent variable on which to focus. Illness rep-
resentations have been noted to impact outcomes in such 
disorders as heart disease [36], rheumatoid arthritis [37], 
Table 3  Multivariate 
regression analyses predicting 
health-related quality of life 
by the psychosocial predictor 
variables controlling for 
demographic variables in adults 
with irritable bowel syndrome
βstandardized regression coefficients (beta weights), R2 percentage of variability in the dependent variable 
(HRQOL mean) explained in the model
*p < 0.05, **p < 0.01, ***p < 0.0001
Predictor variables β 95% CI for β Semi-
partial 
eta-square
Age −0.1179078 −0.5165177 0.2807021 0.0119
Sex (Female) −7.2099430 −12.5963252 −1.8235608 0.0095
Pain −2.3974491 −3.6435407 −1.1513575 0.3131
Catastrophizing −1.1027754 −1.5275834 −0.6779674 0.3149
Anxiety −1.2723519 −2.2751593 −0.2695445 0.0794
Somatization 1.5202876 0.6005868 2.4399884 0.0000
Depression −2.4499983 −3.6279140 −1.2720826 0.0003
Anxiety*somatization −0.1659669 −0.2506989 −0.0812349 0.0353
Anxiety*depression 0.2228991 0.1355720 0.3102263 0.0258
R2 full model 0.79*** NA
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cancer [38, 39], and limited reports in IBS [3, 4]. There is 
persistent evidence for the theoretical predictable relations 
between illness perceptions, coping, and outcomes across 
these studies. Assessment and integration of both cata-
strophizing and illness perceptions into the management 
of individuals who suffer with IBS may maximize health 
outcomes.
There are limitations to this study that need to be 
acknowledged. First, this study relied on patient-reported 
measures. Self-reported responses have been noted as 
potential limitation to studies [40]. There is a risk that a 
participant may be unable to remember information, such 
as description of personal views, feelings, distress level, 
and way of thinking. However, specific to this study it is 
important to note that these are the participant-reported 
perceptions and in contrast may actually have strengthened 
this study by further validating the experience of IBS. Sec-
ond, the sample was relatively small and composed pri-
marily of women from specialty gastrointestinal practices. 
Women are disproportionately affected with IBS [41]. The 
high distribution of women in our sample may be due in 
part to this disproportion in prevalence. The results may 
not generalize to males and/or non-gastrointestinal spe-
cialty practice patients. Given the sample size, results can 
only favor a trend that necessitates confirmation in larger 
sample size studies. In addition, the sample consisted of a 
significant number of participants that catastrophized com-
pared to non-catastrophizers. As noted in the past research 
of individuals who suffer from IBS, there is a tendency to 
catastrophize [5, 42]. It is unclear if this sample is repre-
sentative of this tendency as there is no current literature 
quantifying catastrophizing frequency in an IBS popula-
tion. A final limitation is that our data were cross-sectional 
in nature and as a result cannot speak to the direction, if 
any, of causal effects.
Conclusion
We provide evidence for the importance of assessing cata-
strophizing in individuals with IBS. Development of psy-
chotherapeutic treatment strategies designed specifically 
for those with IBS with the focus to reduce their catastro-
phizing coping through reconceptualization of their IBS by 
altering their thoughts, beliefs, and behaviors may decrease 
the use of maladaptive coping strategies such as catastro-
phizing and result in the enhancement of their HRQOL. 
In addition, considering their illness perceptions has the 
potential to maximize health outcomes in those who suf-
fer from irritable bowel syndrome. Lastly, psychological 
distress continues to remain an important factor in IBS 
management.
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